nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—ALB—chronic obstructive pulmonary disease	0.383	1	CbGaD
Clonazepam—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0967	0.318	CbGbCtD
Clonazepam—ALB—Prednisone—chronic obstructive pulmonary disease	0.0462	0.152	CbGbCtD
Clonazepam—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0455	0.149	CbGbCtD
Clonazepam—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0307	0.101	CbGbCtD
Clonazepam—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0293	0.0963	CbGbCtD
Clonazepam—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0261	0.0858	CbGbCtD
Clonazepam—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0153	0.0504	CbGbCtD
Clonazepam—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0145	0.0476	CbGbCtD
Clonazepam—NAT2—Arylamine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00796	0.126	CbGpPWpGaD
Clonazepam—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00189	0.0299	CbGpPWpGaD
Clonazepam—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00167	0.0264	CbGpPWpGaD
Clonazepam—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00136	0.0216	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00129	0.0205	CbGpPWpGaD
Clonazepam—Niclosamide—CYP1A2—chronic obstructive pulmonary disease	0.00115	0.413	CrCbGaD
Clonazepam—NAT2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00112	0.0177	CbGpPWpGaD
Clonazepam—NAT2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.0011	0.0175	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.000951	0.0151	CbGpPWpGaD
Clonazepam—NAT2—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.000929	0.0147	CbGpPWpGaD
Clonazepam—GABRA3—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.000908	0.0144	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00087	0.0138	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.000848	0.0134	CbGpPWpGaD
Clonazepam—GABRA3—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.000809	0.0128	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.000775	0.0123	CbGpPWpGaD
Clonazepam—NAT2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000774	0.0123	CbGpPWpGaD
Clonazepam—CYP2E1—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00077	0.0122	CbGpPWpGaD
Clonazepam—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.000761	0.0121	CbGpPWpGaD
Clonazepam—NAT2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000712	0.0113	CbGpPWpGaD
Clonazepam—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000692	0.011	CbGpPWpGaD
Clonazepam—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.000678	0.0107	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000654	0.0104	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000646	0.0102	CbGpPWpGaD
Clonazepam—CYP2E1—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000644	0.0102	CbGpPWpGaD
Clonazepam—CYP2E1—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000619	0.00982	CbGpPWpGaD
Clonazepam—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000559	0.00887	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000543	0.00861	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000536	0.00849	CbGpPWpGaD
Clonazepam—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.00053	0.00841	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.000478	0.00757	CbGpPWpGaD
Clonazepam—CYP2E1—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000468	0.00742	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000465	0.00738	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000453	0.00718	CbGpPWpGaD
Clonazepam—CYP2E1—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00045	0.00713	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000447	0.00708	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000444	0.00704	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000426	0.00675	CbGpPWpGaD
Clonazepam—Bromazepam—CYP1A2—chronic obstructive pulmonary disease	0.000423	0.151	CrCbGaD
Clonazepam—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000421	0.00668	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000416	0.0066	CbGpPWpGaD
Clonazepam—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000411	0.00652	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000411	0.00651	CbGpPWpGaD
Clonazepam—NAT2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000395	0.00626	CbGpPWpGaD
Clonazepam—NAT2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000389	0.00617	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000389	0.00616	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000379	0.00601	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.000372	0.0059	CbGpPWpGaD
Clonazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000362	0.00574	CbGpPWpGaD
Clonazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000357	0.00566	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00035	0.00555	CbGpPWpGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000347	0.0055	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000334	0.00529	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000331	0.00525	CbGpPWpGaD
Clonazepam—CYP2E1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000331	0.00524	CbGpPWpGaD
Clonazepam—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000325	0.00515	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000321	0.00508	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00032	0.00507	CbGpPWpGaD
Clonazepam—Flunitrazepam—CYP1A2—chronic obstructive pulmonary disease	0.000319	0.114	CrCbGaD
Clonazepam—NAT2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000318	0.00503	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000316	0.00501	CbGpPWpGaD
Clonazepam—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.00494	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000309	0.0049	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.000303	0.00481	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000303	0.0048	CbGpPWpGaD
Clonazepam—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000299	0.00474	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000295	0.00468	CbGpPWpGaD
Clonazepam—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000287	0.00456	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000285	0.00452	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000282	0.00446	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00028	0.00443	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000274	0.00434	CbGpPWpGaD
Clonazepam—GABRA3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000272	0.00431	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00027	0.00428	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000268	0.00425	CbGpPWpGaD
Clonazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000267	0.00424	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000265	0.0042	CbGpPWpGaD
Clonazepam—CYP2E1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000264	0.00418	CbGpPWpGaD
Clonazepam—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00107	CcSEcCtD
Clonazepam—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000263	0.00107	CcSEcCtD
Clonazepam—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000263	0.00106	CcSEcCtD
Clonazepam—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000263	0.00106	CcSEcCtD
Clonazepam—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000262	0.00106	CcSEcCtD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000261	0.00106	CcSEcCtD
Clonazepam—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000261	0.00106	CcSEcCtD
Clonazepam—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000261	0.00414	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000261	0.00414	CbGpPWpGaD
Clonazepam—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00105	CcSEcCtD
Clonazepam—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.00411	CbGpPWpGaD
Clonazepam—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00104	CcSEcCtD
Clonazepam—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00104	CcSEcCtD
Clonazepam—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00104	CcSEcCtD
Clonazepam—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00104	CcSEcCtD
Clonazepam—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00104	CcSEcCtD
Clonazepam—Infection—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00104	CcSEcCtD
Clonazepam—GABRA3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000256	0.00405	CbGpPWpGaD
Clonazepam—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00103	CcSEcCtD
Clonazepam—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00103	CcSEcCtD
Clonazepam—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00103	CcSEcCtD
Clonazepam—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00103	CcSEcCtD
Clonazepam—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00102	CcSEcCtD
Clonazepam—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00102	CcSEcCtD
Clonazepam—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00102	CcSEcCtD
Clonazepam—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000252	0.00102	CcSEcCtD
Clonazepam—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00102	CcSEcCtD
Clonazepam—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000252	0.00102	CcSEcCtD
Clonazepam—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000251	0.00102	CcSEcCtD
Clonazepam—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000251	0.00102	CcSEcCtD
Clonazepam—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00102	CcSEcCtD
Clonazepam—Infection—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00102	CcSEcCtD
Clonazepam—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00101	CcSEcCtD
Clonazepam—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00101	CcSEcCtD
Clonazepam—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00101	CcSEcCtD
Clonazepam—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000249	0.00101	CcSEcCtD
Clonazepam—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000249	0.00395	CbGpPWpGaD
Clonazepam—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00101	CcSEcCtD
Clonazepam—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000248	0.001	CcSEcCtD
Clonazepam—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000247	0.001	CcSEcCtD
Clonazepam—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000247	0.001	CcSEcCtD
Clonazepam—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000245	0.00389	CbGpPWpGaD
Clonazepam—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000245	0.000993	CcSEcCtD
Clonazepam—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000989	CcSEcCtD
Clonazepam—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.000985	CcSEcCtD
Clonazepam—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.000985	CcSEcCtD
Clonazepam—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.000979	CcSEcCtD
Clonazepam—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000241	0.000975	CcSEcCtD
Clonazepam—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000241	0.000975	CcSEcCtD
Clonazepam—CYP2E1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00024	0.00381	CbGpPWpGaD
Clonazepam—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000239	0.00097	CcSEcCtD
Clonazepam—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000238	0.000966	CcSEcCtD
Clonazepam—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000238	0.000965	CcSEcCtD
Clonazepam—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000237	0.00376	CbGpPWpGaD
Clonazepam—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.000962	CcSEcCtD
Clonazepam—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000236	0.00374	CbGpPWpGaD
Clonazepam—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.000957	CcSEcCtD
Clonazepam—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000236	0.00374	CbGpPWpGaD
Clonazepam—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000235	0.000953	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000235	0.000951	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000235	0.000951	CcSEcCtD
Clonazepam—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000233	0.000944	CcSEcCtD
Clonazepam—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000233	0.000944	CcSEcCtD
Clonazepam—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.000939	CcSEcCtD
Clonazepam—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000232	0.000938	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00023	0.000931	CcSEcCtD
Clonazepam—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00093	CcSEcCtD
Clonazepam—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00093	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000229	0.00363	CbGpPWpGaD
Clonazepam—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000229	0.000928	CcSEcCtD
Clonazepam—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000229	0.000928	CcSEcCtD
Clonazepam—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000228	0.000924	CcSEcCtD
Clonazepam—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000228	0.00361	CbGpPWpGaD
Clonazepam—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.000921	CcSEcCtD
Clonazepam—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000227	0.000919	CcSEcCtD
Clonazepam—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.000919	CcSEcCtD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000226	0.00359	CbGpPWpGaD
Clonazepam—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000226	0.000915	CcSEcCtD
Clonazepam—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000224	0.000909	CcSEcCtD
Clonazepam—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000224	0.000907	CcSEcCtD
Clonazepam—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000223	0.000904	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.000901	CcSEcCtD
Clonazepam—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000222	0.000901	CcSEcCtD
Clonazepam—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000222	0.0009	CcSEcCtD
Clonazepam—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.0009	CcSEcCtD
Clonazepam—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000222	0.0009	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000222	0.000898	CcSEcCtD
Clonazepam—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.000892	CcSEcCtD
Clonazepam—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00022	0.000892	CcSEcCtD
Clonazepam—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.000892	CcSEcCtD
Clonazepam—Pain—Formoterol—chronic obstructive pulmonary disease	0.00022	0.000892	CcSEcCtD
Clonazepam—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00022	0.000891	CcSEcCtD
Clonazepam—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000889	CcSEcCtD
Clonazepam—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000889	CcSEcCtD
Clonazepam—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000219	0.00346	CbGpPWpGaD
Clonazepam—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000218	0.000882	CcSEcCtD
Clonazepam—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000217	0.000881	CcSEcCtD
Clonazepam—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000217	0.00344	CbGpPWpGaD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000217	0.00344	CbGpPWpGaD
Clonazepam—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.000878	CcSEcCtD
Clonazepam—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.000876	CcSEcCtD
Clonazepam—Pain—Montelukast—chronic obstructive pulmonary disease	0.000216	0.000874	CcSEcCtD
Clonazepam—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000215	0.000872	CcSEcCtD
Clonazepam—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000214	0.000869	CcSEcCtD
Clonazepam—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000214	0.0034	CbGpPWpGaD
Clonazepam—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.000867	CcSEcCtD
Clonazepam—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000213	0.000865	CcSEcCtD
Clonazepam—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000213	0.000864	CcSEcCtD
Clonazepam—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00086	CcSEcCtD
Clonazepam—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00086	CcSEcCtD
Clonazepam—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.000859	CcSEcCtD
Clonazepam—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.000857	CcSEcCtD
Clonazepam—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000856	CcSEcCtD
Clonazepam—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000211	0.000855	CcSEcCtD
Clonazepam—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000211	0.000853	CcSEcCtD
Clonazepam—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.000853	CcSEcCtD
Clonazepam—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000853	CcSEcCtD
Clonazepam—NAT2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00021	0.00334	CbGpPWpGaD
Clonazepam—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.000851	CcSEcCtD
Clonazepam—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00085	CcSEcCtD
Clonazepam—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000209	0.00331	CbGpPWpGaD
Clonazepam—GABRA3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000208	0.00331	CbGpPWpGaD
Clonazepam—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000208	0.0745	CrCbGaD
Clonazepam—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.000843	CcSEcCtD
Clonazepam—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.000843	CcSEcCtD
Clonazepam—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000207	0.00329	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000207	0.00328	CbGpPWpGaD
Clonazepam—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000206	0.000836	CcSEcCtD
Clonazepam—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000206	0.000836	CcSEcCtD
Clonazepam—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000206	0.00326	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GC—chronic obstructive pulmonary disease	0.000205	0.00324	CbGpPWpGaD
Clonazepam—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000205	0.000829	CcSEcCtD
Clonazepam—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000205	0.000829	CcSEcCtD
Clonazepam—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.000825	CcSEcCtD
Clonazepam—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.000825	CcSEcCtD
Clonazepam—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000204	0.000825	CcSEcCtD
Clonazepam—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000204	0.000825	CcSEcCtD
Clonazepam—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000203	0.0727	CrCbGaD
Clonazepam—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000822	CcSEcCtD
Clonazepam—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000203	0.000822	CcSEcCtD
Clonazepam—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000816	CcSEcCtD
Clonazepam—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.000815	CcSEcCtD
Clonazepam—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.000815	CcSEcCtD
Clonazepam—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000201	0.000814	CcSEcCtD
Clonazepam—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000201	0.0718	CrCbGaD
Clonazepam—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.0002	0.000812	CcSEcCtD
Clonazepam—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.000812	CcSEcCtD
Clonazepam—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00081	CcSEcCtD
Clonazepam—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.0002	0.00317	CbGpPWpGaD
Clonazepam—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000199	0.000808	CcSEcCtD
Clonazepam—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000199	0.000808	CcSEcCtD
Clonazepam—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000807	CcSEcCtD
Clonazepam—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.000806	CcSEcCtD
Clonazepam—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.000799	CcSEcCtD
Clonazepam—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000798	CcSEcCtD
Clonazepam—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.000795	CcSEcCtD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000196	0.00311	CbGpPWpGaD
Clonazepam—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000795	CcSEcCtD
Clonazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000195	0.0031	CbGpPWpGaD
Clonazepam—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000792	CcSEcCtD
Clonazepam—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000194	0.00308	CbGpPWpGaD
Clonazepam—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.000783	CcSEcCtD
Clonazepam—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.000779	CcSEcCtD
Clonazepam—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.000779	CcSEcCtD
Clonazepam—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.00304	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00019	0.00302	CbGpPWpGaD
Clonazepam—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00019	0.000769	CcSEcCtD
Clonazepam—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.000769	CcSEcCtD
Clonazepam—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.000768	CcSEcCtD
Clonazepam—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000189	0.000767	CcSEcCtD
Clonazepam—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000186	0.000753	CcSEcCtD
Clonazepam—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000185	0.000749	CcSEcCtD
Clonazepam—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.000749	CcSEcCtD
Clonazepam—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000183	0.00291	CbGpPWpGaD
Clonazepam—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000182	0.000738	CcSEcCtD
Clonazepam—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000182	0.000738	CcSEcCtD
Clonazepam—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000737	CcSEcCtD
Clonazepam—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000181	0.000733	CcSEcCtD
Clonazepam—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.000726	CcSEcCtD
Clonazepam—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000178	0.000723	CcSEcCtD
Clonazepam—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.000714	CcSEcCtD
Clonazepam—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000176	0.000714	CcSEcCtD
Clonazepam—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000175	0.00277	CbGpPWpGaD
Clonazepam—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000707	CcSEcCtD
Clonazepam—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000173	0.000699	CcSEcCtD
Clonazepam—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.000697	CcSEcCtD
Clonazepam—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.00069	CcSEcCtD
Clonazepam—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00017	0.00069	CcSEcCtD
Clonazepam—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.000169	0.0606	CrCbGaD
Clonazepam—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000169	0.00267	CbGpPWpGaD
Clonazepam—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000676	CcSEcCtD
Clonazepam—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.000674	CcSEcCtD
Clonazepam—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000665	CcSEcCtD
Clonazepam—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000164	0.000663	CcSEcCtD
Clonazepam—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.000663	CcSEcCtD
Clonazepam—Rash—Formoterol—chronic obstructive pulmonary disease	0.000162	0.000658	CcSEcCtD
Clonazepam—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.000658	CcSEcCtD
Clonazepam—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.000657	CcSEcCtD
Clonazepam—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000162	0.000657	CcSEcCtD
Clonazepam—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000657	CcSEcCtD
Clonazepam—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.000654	CcSEcCtD
Clonazepam—Headache—Formoterol—chronic obstructive pulmonary disease	0.000161	0.000654	CcSEcCtD
Clonazepam—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000653	CcSEcCtD
Clonazepam—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000161	0.000653	CcSEcCtD
Clonazepam—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000652	CcSEcCtD
Clonazepam—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00016	0.00065	CcSEcCtD
Clonazepam—Rash—Montelukast—chronic obstructive pulmonary disease	0.000159	0.000644	CcSEcCtD
Clonazepam—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000159	0.000644	CcSEcCtD
Clonazepam—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000642	CcSEcCtD
Clonazepam—Depression—Prednisone—chronic obstructive pulmonary disease	0.000158	0.000642	CcSEcCtD
Clonazepam—Headache—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00064	CcSEcCtD
Clonazepam—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.0025	CbGpPWpGaD
Clonazepam—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000633	CcSEcCtD
Clonazepam—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000631	CcSEcCtD
Clonazepam—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.000626	CcSEcCtD
Clonazepam—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000624	CcSEcCtD
Clonazepam—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000622	CcSEcCtD
Clonazepam—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000153	0.00243	CbGpPWpGaD
Clonazepam—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000621	CcSEcCtD
Clonazepam—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.000621	CcSEcCtD
Clonazepam—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00062	CcSEcCtD
Clonazepam—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00062	CcSEcCtD
Clonazepam—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.000617	CcSEcCtD
Clonazepam—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000152	0.0024	CbGpPWpGaD
Clonazepam—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00015	0.000607	CcSEcCtD
Clonazepam—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000585	CcSEcCtD
Clonazepam—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000144	0.000582	CcSEcCtD
Clonazepam—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000581	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000143	0.00227	CbGpPWpGaD
Clonazepam—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000578	CcSEcCtD
Clonazepam—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000142	0.000575	CcSEcCtD
Clonazepam—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000568	CcSEcCtD
Clonazepam—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000565	CcSEcCtD
Clonazepam—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000139	0.000565	CcSEcCtD
Clonazepam—CYP2E1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000139	0.0022	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000137	0.00218	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000137	0.00217	CbGpPWpGaD
Clonazepam—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.000552	CcSEcCtD
Clonazepam—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000135	0.00214	CbGpPWpGaD
Clonazepam—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00054	CcSEcCtD
Clonazepam—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000132	0.000536	CcSEcCtD
Clonazepam—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00013	0.00205	CbGpPWpGaD
Clonazepam—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000522	CcSEcCtD
Clonazepam—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000127	0.00201	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000127	0.00201	CbGpPWpGaD
Clonazepam—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000126	0.000511	CcSEcCtD
Clonazepam—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000511	CcSEcCtD
Clonazepam—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000506	CcSEcCtD
Clonazepam—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000503	CcSEcCtD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000124	0.00197	CbGpPWpGaD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00194	CbGpPWpGaD
Clonazepam—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.000483	CcSEcCtD
Clonazepam—Diazepam—ALB—chronic obstructive pulmonary disease	0.000117	0.042	CrCbGaD
Clonazepam—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000474	CcSEcCtD
Clonazepam—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000467	CcSEcCtD
Clonazepam—CYP2E1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.00183	CbGpPWpGaD
Clonazepam—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000466	CcSEcCtD
Clonazepam—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000465	CcSEcCtD
Clonazepam—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000462	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000114	0.0018	CbGpPWpGaD
Clonazepam—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00046	CcSEcCtD
Clonazepam—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000454	CcSEcCtD
Clonazepam—NAT2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000112	0.00177	CbGpPWpGaD
Clonazepam—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000452	CcSEcCtD
Clonazepam—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000111	0.00177	CbGpPWpGaD
Clonazepam—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000111	0.000449	CcSEcCtD
Clonazepam—NAT2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00011	0.00175	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000109	0.00173	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000108	0.00171	CbGpPWpGaD
Clonazepam—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000428	CcSEcCtD
Clonazepam—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000428	CcSEcCtD
Clonazepam—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000105	0.00167	CbGpPWpGaD
Clonazepam—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000427	CcSEcCtD
Clonazepam—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000105	0.00167	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	0.000105	0.00167	CbGpPWpGaD
Clonazepam—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000425	CcSEcCtD
Clonazepam—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000423	CcSEcCtD
Clonazepam—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000416	CcSEcCtD
Clonazepam—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000411	CcSEcCtD
Clonazepam—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000411	CcSEcCtD
Clonazepam—NAT2—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000101	0.0016	CbGpPWpGaD
Clonazepam—Infection—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000408	CcSEcCtD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.00159	CbGpPWpGaD
Clonazepam—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.94e-05	0.000403	CcSEcCtD
Clonazepam—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.89e-05	0.000401	CcSEcCtD
Clonazepam—Skin disorder—Prednisone—chronic obstructive pulmonary disease	9.84e-05	0.000399	CcSEcCtD
Clonazepam—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.66e-05	0.000391	CcSEcCtD
Clonazepam—CYP2E1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	9.6e-05	0.00152	CbGpPWpGaD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	9.47e-05	0.0015	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	9.45e-05	0.0015	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.29e-05	0.00147	CbGpPWpGaD
Clonazepam—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.23e-05	0.000374	CcSEcCtD
Clonazepam—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.22e-05	0.000374	CcSEcCtD
Clonazepam—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.17e-05	0.000371	CcSEcCtD
Clonazepam—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	9.13e-05	0.00145	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	9.03e-05	0.00143	CbGpPWpGaD
Clonazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	9.01e-05	0.00143	CbGpPWpGaD
Clonazepam—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.000361	CcSEcCtD
Clonazepam—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	8.9e-05	0.00141	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.83e-05	0.0014	CbGpPWpGaD
Clonazepam—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.81e-05	0.000357	CcSEcCtD
Clonazepam—Rash—Prednisolone—chronic obstructive pulmonary disease	8.79e-05	0.000356	CcSEcCtD
Clonazepam—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.79e-05	0.000356	CcSEcCtD
Clonazepam—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.74e-05	0.000354	CcSEcCtD
Clonazepam—Headache—Prednisolone—chronic obstructive pulmonary disease	8.74e-05	0.000354	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	8.7e-05	0.00138	CbGpPWpGaD
Clonazepam—Constipation—Prednisone—chronic obstructive pulmonary disease	8.67e-05	0.000351	CcSEcCtD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	8.61e-05	0.00136	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	8.56e-05	0.00136	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	8.37e-05	0.00133	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	8.37e-05	0.00133	CbGpPWpGaD
Clonazepam—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	8.37e-05	0.00133	CbGpPWpGaD
Clonazepam—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.000338	CcSEcCtD
Clonazepam—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.29e-05	0.000336	CcSEcCtD
Clonazepam—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.28e-05	0.000336	CcSEcCtD
Clonazepam—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	8.25e-05	0.00131	CbGpPWpGaD
Clonazepam—Urticaria—Prednisone—chronic obstructive pulmonary disease	8.05e-05	0.000326	CcSEcCtD
Clonazepam—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000325	CcSEcCtD
Clonazepam—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.000325	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	7.83e-05	0.00124	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.75e-05	0.00123	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.64e-05	0.00121	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	7.64e-05	0.00121	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	7.51e-05	0.00119	CbGpPWpGaD
Clonazepam—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.47e-05	0.000303	CcSEcCtD
Clonazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	7.31e-05	0.00116	CbGpPWpGaD
Clonazepam—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.27e-05	0.000295	CcSEcCtD
Clonazepam—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.17e-05	0.000291	CcSEcCtD
Clonazepam—NAT2—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.12e-05	0.00113	CbGpPWpGaD
Clonazepam—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.93e-05	0.000281	CcSEcCtD
Clonazepam—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	6.8e-05	0.00108	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.75e-05	0.00107	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	6.73e-05	0.00107	CbGpPWpGaD
Clonazepam—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.7e-05	0.000272	CcSEcCtD
Clonazepam—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.5e-05	0.00103	CbGpPWpGaD
Clonazepam—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.44e-05	0.000261	CcSEcCtD
Clonazepam—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	6.43e-05	0.00102	CbGpPWpGaD
Clonazepam—Rash—Prednisone—chronic obstructive pulmonary disease	6.39e-05	0.000259	CcSEcCtD
Clonazepam—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.38e-05	0.000259	CcSEcCtD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	6.36e-05	0.00101	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	6.35e-05	0.00101	CbGpPWpGaD
Clonazepam—Headache—Prednisone—chronic obstructive pulmonary disease	6.35e-05	0.000257	CcSEcCtD
Clonazepam—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	6.21e-05	0.000985	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	6.21e-05	0.000985	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	6.2e-05	0.000982	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	6.16e-05	0.000977	CbGpPWpGaD
Clonazepam—Nausea—Prednisone—chronic obstructive pulmonary disease	6.02e-05	0.000244	CcSEcCtD
Clonazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.94e-05	0.000942	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	5.92e-05	0.000939	CbGpPWpGaD
Clonazepam—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	5.79e-05	0.000917	CbGpPWpGaD
Clonazepam—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	5.7e-05	0.000904	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	5.48e-05	0.000868	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	5.45e-05	0.000865	CbGpPWpGaD
Clonazepam—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	5.43e-05	0.000862	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	5.43e-05	0.000861	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.34e-05	0.000847	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.27e-05	0.000835	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.19e-05	0.000823	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	5.01e-05	0.000795	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.93e-05	0.000782	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	4.71e-05	0.000746	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—ALB—chronic obstructive pulmonary disease	4.59e-05	0.000727	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.46e-05	0.000707	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.46e-05	0.000707	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.4e-05	0.000698	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.39e-05	0.000697	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.39e-05	0.000696	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	4.34e-05	0.000688	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	4.22e-05	0.000669	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.12e-05	0.000654	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.09e-05	0.000649	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.04e-05	0.00064	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.03e-05	0.000639	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	4.01e-05	0.000635	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.98e-05	0.000631	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.9e-05	0.000618	CbGpPWpGaD
Clonazepam—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.88e-05	0.000615	CbGpPWpGaD
Clonazepam—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.83e-05	0.000608	CbGpPWpGaD
Clonazepam—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.83e-05	0.000607	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.81e-05	0.000604	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.8e-05	0.000603	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GC—chronic obstructive pulmonary disease	3.73e-05	0.000591	CbGpPWpGaD
Clonazepam—GABRA3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.72e-05	0.00059	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.57e-05	0.000566	CbGpPWpGaD
Clonazepam—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.47e-05	0.00055	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.12e-05	0.000495	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.12e-05	0.000494	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.97e-05	0.000471	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.76e-05	0.000438	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.76e-05	0.000437	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.72e-05	0.000431	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.67e-05	0.000423	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.53e-05	0.000401	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.45e-05	0.000389	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.37e-05	0.000376	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.34e-05	0.000371	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.14e-05	0.000339	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.07e-05	0.000328	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.07e-05	0.000328	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.04e-05	0.000323	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	2.01e-05	0.000319	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.01e-05	0.000319	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.97e-05	0.000313	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.97e-05	0.000312	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.87e-05	0.000297	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.000291	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.69e-05	0.000268	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.64e-05	0.00026	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.62e-05	0.000257	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.51e-05	0.000239	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000227	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.42e-05	0.000225	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.41e-05	0.000224	CbGpPWpGaD
Clonazepam—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.39e-05	0.000221	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.3e-05	0.000207	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.3e-05	0.000206	CbGpPWpGaD
Clonazepam—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.23e-05	0.000195	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.1e-05	0.000174	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.09e-05	0.000172	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	1.07e-05	0.00017	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	9.92e-06	0.000157	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	9.73e-06	0.000154	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.3e-06	0.000148	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.14e-06	0.000145	CbGpPWpGaD
Clonazepam—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	8e-06	0.000127	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.62e-06	0.000121	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.52e-06	0.000119	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	7e-06	0.000111	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.64e-06	0.000105	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	4.51e-06	7.15e-05	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	4.32e-06	6.84e-05	CbGpPWpGaD
